sponsored
PatientsVille.com Logo

PatientsVille

Loratadine and Alprazolam

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectLoratadineAlprazolam
COMPLETED SUICIDE0% 4.3%
DRUG ABUSE0% 4.2%
DRUG INEFFECTIVE4.1% 2.8%
TOXICITY TO VARIOUS AGENTS0.5% 3.2%
NAUSEA3.1% 2.6%
FATIGUE3.1% 2.4%
DYSPNOEA2.9% 1.9%
HEADACHE2.6% 1.9%
DIZZINESS2.6% 1.7%
DEATH0.9% 2.6%
DIARRHOEA2.4% 1.9%
PAIN2.2% 1.9%
CARDIAC ARREST0% 2.2%
ANXIETY1.4% 2.1%
OFF LABEL USE1.9% 1%
RESPIRATORY ARREST0% 1.9%
MALAISE1.8% 1.4%
VOMITING1.7% 1.5%
CARDIO-RESPIRATORY ARREST0% 1.7%
ASTHENIA1.6% 1.5%
FALL1.5% 1.6%
DEPRESSION1.4% 1.6%
INSOMNIA1.5% 1.4%
PNEUMONIA1.5% 1.1%
RASH1.5% 0.9%
SOMNOLENCE1.4% 1.3%
ARTHRALGIA1.4% 1%
PAIN IN EXTREMITY1.4% 0.9%
COUGH1.4% 0.7%
PYREXIA1.3% 0.9%
PRURITUS1.3% 0.7%
BACK PAIN1.2% 0.9%
CHEST PAIN1.2% 0.9%
OVERDOSE0.5% 1.2%
FEELING ABNORMAL1.1% 1.1%
WEIGHT DECREASED1.1% 1.1%
CONDITION AGGRAVATED1.1% 0.8%
POISONING0% 1.1%
HYPERTENSION1% 1%
CONSTIPATION1% 0.9%
WEIGHT INCREASED1% 0.9%
TREMOR0.8% 1%
DRUG INTERACTION0.7% 1%
URTICARIA1% 0%
CONFUSIONAL STATE0.9% 0.9%
DECREASED APPETITE0.9% 0.8%
ABDOMINAL PAIN0.9% 0.8%
ABDOMINAL PAIN UPPER0.9% 0.7%
MUSCLE SPASMS0.9% 0.7%
HYPOTENSION0.7% 0.9%
HYPERSENSITIVITY0.9% 0%
ASTHMA0.9% 0%
GAIT DISTURBANCE0.7% 0.8%
HYPOAESTHESIA0.8% 0.6%
URINARY TRACT INFECTION0.8% 0.6%
DRUG DOSE OMISSION0.8% 0.6%
SUICIDE ATTEMPT0% 0.8%
SINUSITIS0.8% 0%
ANAEMIA0.7% 0.7%
RENAL FAILURE0.7% 0.7%
ACUTE KIDNEY INJURY0.7% 0.7%
OEDEMA PERIPHERAL0.7% 0.6%
DEHYDRATION0.7% 0.6%
HYPERHIDROSIS0.7% 0.6%
BLOOD PRESSURE INCREASED0.7% 0.6%
LOSS OF CONSCIOUSNESS0.6% 0.7%
PARAESTHESIA0.7% 0.6%
ALOPECIA0.7% 0.5%
PALPITATIONS0.7% 0.5%
MYALGIA0.7% 0.5%
CHRONIC KIDNEY DISEASE0.7% 0.5%
GASTROOESOPHAGEAL REFLUX DISEASE0.7% 0.4%
CHEST DISCOMFORT0.7% 0%
INTENTIONAL OVERDOSE0% 0.7%
NASOPHARYNGITIS0.7% 0%
COMA0% 0.7%
MEMORY IMPAIRMENT0.6% 0.6%
ABDOMINAL DISCOMFORT0.6% 0.5%
SUICIDAL IDEATION0.5% 0.6%
VISION BLURRED0.6% 0.5%
CEREBROVASCULAR ACCIDENT0.6% 0.5%
MYOCARDIAL INFARCTION0.6% 0.5%
SYNCOPE0.6% 0.4%
ERYTHEMA0.6% 0.4%
DRUG HYPERSENSITIVITY0.6% 0.4%
HEART RATE INCREASED0.6% 0.4%
DRY MOUTH0.6% 0%
INJECTION SITE PAIN0.6% 0%
INCORRECT DOSE ADMINISTERED0.6% 0%
PERIPHERAL SWELLING0.6% 0%
BLOOD GLUCOSE INCREASED0.5% 0.5%
AGITATION0.5% 0.5%
PULMONARY EMBOLISM0.5% 0.4%
BALANCE DISORDER0.5% 0.4%
GASTROINTESTINAL HAEMORRHAGE0.5% 0.4%
ATRIAL FIBRILLATION0.5% 0.4%
INTENTIONAL PRODUCT MISUSE0% 0.5%
SOPOR0% 0.5%
DRUG DEPENDENCE0% 0.5%
INTENTIONAL DRUG MISUSE0% 0.5%
HAEMOGLOBIN DECREASED0.5% 0%
SWELLING FACE0.5% 0%
OROPHARYNGEAL PAIN0.5% 0%
EPISTAXIS0.5% 0%
FLUSHING0.5% 0%
CHILLS0.5% 0%
BRONCHITIS0.5% 0%
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION0.5% 0%
DYSPEPSIA0.5% 0%
EXPIRED PRODUCT ADMINISTERED0.5% 0%
MUSCULAR WEAKNESS0.5% 0%
SEPSIS0.5% 0%
PRODUCT USE ISSUE0.5% 0%
ACCIDENTAL OVERDOSE0% 0.4%
DRUG WITHDRAWAL SYNDROME0% 0.4%
TACHYCARDIA0% 0.4%
PANIC ATTACK0% 0.4%
AMNESIA0% 0.4%
INJURY0% 0.4%
DIABETES MELLITUS0% 0.4%
DRUG TOXICITY0% 0.4%
CONTUSION0% 0.4%
THROMBOCYTOPENIA0% 0.4%

New treatments are found every day. View current Loratadine research studies and Alprazolam clinical trials

1